Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Urine TWEAK level as a biomarker for early response to treatment in active lupus nephritis: a prospective multicentre study.

Suttichet TB, Kittanamongkolchai W, Phromjeen C, Anutrakulchai S, Panaput T, Ingsathit A, Kamanamool N, Ophascharoensuk V, Sumethakul V, Avihingsanon Y.

Lupus Sci Med. 2019 Apr 9;6(1):e000298. doi: 10.1136/lupus-2018-000298. eCollection 2019.

2.

Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype-guided doses in renal transplantation patients.

Anutrakulchai S, Pongskul C, Kritmetapak K, Limwattananon C, Vannaprasaht S.

Br J Clin Pharmacol. 2019 May 11. doi: 10.1111/bcp.13980. [Epub ahead of print]

PMID:
31077425
3.

Effect of CYP3A5 genotype on hospitalization cost for kidney transplantation.

Vannaprasaht S, Limwattananon C, Anutrakulchai S, Chan-On C.

Int J Clin Pharm. 2019 Feb;41(1):88-95. doi: 10.1007/s11096-018-0750-5. Epub 2018 Nov 16.

PMID:
30446894
4.

Clinical and pathological characteristics of non-diabetic renal disease in type 2 diabetes patients.

Kritmetapak K, Anutrakulchai S, Pongchaiyakul C, Puapairoj A.

Clin Kidney J. 2018 Jun;11(3):342-347. doi: 10.1093/ckj/sfx111. Epub 2017 Sep 18.

5.

Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.

Kamanamool N, Ingsathit A, Rattanasiri S, Ngamjanyaporn P, Kasitanont N, Chawanasuntorapoj R, Pichaiwong W, Anutrakulchai S, Sangthawan P, Ophascharoensuk V, Avihingsanon Y, Sumethkul V.

Lupus. 2018 Apr;27(4):647-656. doi: 10.1177/0961203317739131. Epub 2017 Nov 6.

PMID:
29105558
6.

Prevalence of insomnia and related impact.

Manjavong M, Limpawattana P, Mairiang P, Anutrakulchai S.

Int J Psychiatry Med. 2016 Aug;51(6):544-553. doi: 10.1177/0091217417696731. Epub 2017 Mar 12.

PMID:
28629294
7.

Relation of peritubular capillary features to class of lupus nephritis.

Anutrakulchai S, Titipungul T, Pattay T, Mesung P, Puapairoj A, Sirivongs D, Pongsakul C, Futrakul P, Thinkhamrop B, Johnson RJ.

BMC Nephrol. 2016 Nov 9;17(1):169.

8.

Erratum to: Mortality and treatment costs of hospitalized chronic kidney disease patients between the three major health insurance schemes in Thailand.

Anutrakulchai S, Mairiang P, Pongskul C, Thepsuthammarat K, Chan-On C, Thinkhamrop B.

BMC Health Serv Res. 2016 Oct 25;16(1):614. No abstract available.

9.

Mortality and treatment costs of hospitalized chronic kidney disease patients between the three major health insurance schemes in Thailand.

Anutrakulchai S, Mairiang P, Pongskul C, Thepsuthammarat K, Chan-On C, Thinkhamrop B.

BMC Health Serv Res. 2016 Sep 29;16(1):528. Erratum in: BMC Health Serv Res. 2016 Oct 25;16(1):614.

10.

Climate Change and the Emergent Epidemic of CKD from Heat Stress in Rural Communities: The Case for Heat Stress Nephropathy.

Glaser J, Lemery J, Rajagopalan B, Diaz HF, García-Trabanino R, Taduri G, Madero M, Amarasinghe M, Abraham G, Anutrakulchai S, Jha V, Stenvinkel P, Roncal-Jimenez C, Lanaspa MA, Correa-Rotter R, Sheikh-Hamad D, Burdmann EA, Andres-Hernando A, Milagres T, Weiss I, Kanbay M, Wesseling C, Sánchez-Lozada LG, Johnson RJ.

Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1472-83. doi: 10.2215/CJN.13841215. Epub 2016 May 5. Review.

11.

A multicentre, randomised controlled study of enteric-coated mycophenolate sodium for the treatment of relapsed or resistant proliferative lupus nephritis: an Asian experience.

Anutrakulchai S, Panaput T, Wongchinsri J, Chaishayanon S, Satirapoj B, Traitanon O, Pima W, Rukrung C, Thinkhamrop B, Avihingsanon Y.

Lupus Sci Med. 2016 Jan 14;3(1):e000120. doi: 10.1136/lupus-2015-000120. eCollection 2016.

12.

Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: a prospective cohort study.

Panaput T, Thinkhamrop B, Domrongkitchaiporn S, Sirivongs D, Praderm L, Anukulanantachai J, Kanokkantapong C, Tungkasereerak P, Pongskul C, Anutrakulchai S, Keobounma T, Narenpitak S, Intarawongchot P, Suwattanasin A, Tatiyanupanwong S, Niwattayakul K.

Blood Purif. 2014;38(3-4):253-62. doi: 10.1159/000368885. Epub 2015 Jan 6.

13.

The effect of prostaglandin E1 analog misoprostol on chronic cyclosporin nephrotoxicity.

John EG, Fornell LC, Radhakrishnan J, Anutrakulchai S, Jonasson O.

J Pediatr Surg. 1993 Nov;28(11):1429-31; discussion 1432.

PMID:
8301454

Supplemental Content

Loading ...
Support Center